Biocept Inc (NASDAQ:BIOC) announced Friday that data validating the ability of its Target Selector platform to identify actionable mutations in the cerebrospinal fluid of cancer patients was presented at the American Society for Clinical Oncology 2020 Virtual Scientific Program. The presentation showed higher sensitivity with Target Selector in detecting cancer material and identifying leptomeningeal metastases in cerebrospinal fluid compared with cerebrospinal fluid cytology, the standard-of-care technology. Biocept’s Target Selector assays are able to detect circulating tumor cells and circulating DNA and identify cancer-associated biomarkers in the cerebrospinal fluid.
EnWave Corporation (CVE:ENW) (OTCPINK:NWVCF) revealed Friday that it continued to see strong revenue contributions during its second quarter from its Radiant Energy Vacuum machine. The Vancouver-based company said its EnWave business line, which manufactures and installs the dehydration technology for food and cannabis verticals, delivered C$2.2 million in revenue during its second quarter ended March 30, 2020, an 8% increase from the C$2 million it put up in the same quarter a year earlier. The company signed a number of new royalty-bearing commercial license agreements in Australia and Colombia and completed the installation of a 120kW REV processing line for a fruit producer in Idaho during the three-month period ended March 30.
Lingo Media Corporation (CVE:LM) (OTCQB:LMDCF) announced Friday it turned a year-over-year net profit during its first quarter of 2020 as the EdTech company added new customers and key distributors. Net profit for the quarter ended March 31 was C$233,619, or C$0.01 a share, compared to a net loss of C$314,522, or C$0.00 loss per share, in 2019, according to a statement. Income before amortization, share-based payments, depreciation, finance charges and taxes was C$246,057, compared to the loss of C$328,441 in 1Q 2019.
Maverix Metals Inc (TSE:MMX) (NYSEAMERICAN:MMX) and Pan American Silver Corp (TSE:PAAS) (NASDAQ:PAAS) have entered into an underwriting agreement with a syndicate of underwriters for a secondary offering of Maverix shares held by Pan American. Under the agreement, 9 million common shares will be sold for US$4.40 each for gross proceeds of US$39.6 million, according to a statement. Pan American has granted the underwriters over-allotment option — exercisable in whole or in part for a period of 30 days following the closing of the secondary offering — to purchase up to an additional 1,350,000 of Maverix shares currently held by Pan American at the offering price. If the over-allotment option is exercised in full, the total gross proceeds to Pan American will be US$45,540,000.
Thunderbird Entertainment Group Inc (CVE:TBRD) (OTCMKTS:THBRF) posted fiscal third-quarter results on Friday that saw its revenue jump by 40% year-over-year driven by tremendous growth in the content producer’s kids and family division. For its fiscal third quarter ended March 31, 2020, the Vancouver-based producer of titles like The Last Kids on Earth and Molly of Denali reported revenue of $29.3 million, compared to $20.9 million in the fiscal third quarter of 2019. Similarly, Thunderbird clocked up revenue of $59.6 million for the nine months ended March 31, 2020, compared to $44.7 million for the same period in fiscal 2019. Thunderbird achieved a record quarterly adjusted EBITDA, or earnings before interest, taxes, depreciation, and amortization, of $6.9 million, up 45% from the fiscal third quarter in 2019.
Codebase Ventures Inc (CSE:CODE) (OTCQB:BKLLF), a venture capital company investing in early-stage technology and cannabis companies, has announced that its psychedelic-selling investee Red Light Holland began trading on the CSE Friday under the ticker symbol TRIP. Red Light Holland, based in the Netherlands, grows and sells premium magic truffles in the legal Dutch recreational market through retail stores known as Smart Shops and online. Codebase invested in the company back in January through its subsidiary Titan Shrooms & Psychedelics Inc.
Phunware Inc (NASDAQ:PHUN), an enterprise cloud platform for mobile that provides products, solutions, data and services for brands, said Friday that it is now TRUSTe certified which recognizes the group’s strong global compliance and privacy policies. In a statement, Austin, Texas-based Phunware said the group “successfully met” the stringent data collection TRUSTe certification standards stipulated by TrustArc, a non-profit industry association that helps businesses and organizations regulate global privacy concerns. “An independent third-party review and certification from TrustArc for TRUSTe attestation demonstrates privacy compliance and a high commitment globally to following data collection best practices,” the company said in a statement.
Champignon Brands Inc (CSE:SHRM) (OTCQB:SHRMF), a wellness company focused on areas of psychedelic medicine, said it has retained Gold Standard Media LLC (GSM) to provide marketing and consulting services as the firm moves to expand its North American clinical footprint. The initial agreement with GSM covers a two-year term effective May 28, 2020, at an aggregate cost of US$300,000. Neither GSM nor its principals hold any securities of Champignon, according to the company. Champignon also announced a voluntary share lockup on Friday of 17.84 million shares. The psychedelic medicine firm said certain shareholders have agreed to a voluntary resale restriction period, extending the period of time before the shares become free trading to July 15, 2020.
TRACON Pharmaceuticals Inc (NASDAQ:TCON), which is planning to start the ENVASARC study of its envafolimab novel, single-domain antibody in combination with immunotherapy Yervoy as a treatment for sarcoma later in 2020, has highlighted data from a separate study that buoys the potential of its drug. In a statement Friday, the company cited a study done by the Alliance for Clinical Trials in Oncology at the American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program. TRACON said the Alliance study reported an impressive 29% confirmed objective response rate (ORR) in patients with highly refractory Undifferentiated Pleomorphic Sarcoma (UPS) who received Opdivo, a prescription medication that treats certain types of cancer, in combination with Yervoy in a non-comparative randomized trial.
Ximen Mining Corp (CVE:XIM) (OTCMKTS:XXMMF) updated Friday on the further progress being made at its Kenville gold mine project in Nelson, British Columbia. In March, Ximen said it would start by refurbishing the existing portal at the 257 level of the mine and on Friday the firm revealed that this work has started. This refurbishment is needed before a new decline can be constructed once Ximen receives final regulatory approval for its development program. In Friday’s brief statement, Ximen said it had recently bought a steel culvert for installation at the portal. Once assembled it will be transported to the site in early June.
Atlas Engineered Products Ltd (CVE:AEP) (OTCPINK:APEUF) has said it will make use of the extension offered by the Canadian Securities Administrators (CSA) in the light of the coronavirus (COVID-19) pandemic to file its first-quarter results. In March, the CSA granted public issuers a 45-day extension for filings required on or before June 1 this year. The deadline for the quarterly filings has been extended to July 16 this year. “As part of our health and safety response to COVID-19 across Canada, we arranged for various non-manufacturing team members to work remotely,” said Melissa MacRae, the company’s interim CFO. “These measures reduced our ability to externally report during the pandemic. Our team members have now adjusted to new COVID-19 practices and work arrangements, again reduced our internal and external report time. Going forward, we expect that all reporting will be timely once again.”
Medgold Resources Corp. (CVE:MED) (FRA:1XD) has announced that further to its news release of April 28, 2020, the company is continuing to rely on the extension provided by the securities regulators as a result of the coronavirus (COVID-19) pandemic regarding the deadline for filing and delivering its audited financial statements and MD&A for the fiscal year ended December 31, 2019. Accordingly, the company said it will file such financials no later than the extended deadline of June 15, 2020. Medgold also confirmed that due to the delay in filing its annual financials, it will also rely on the extension provided regarding the deadline for filing and delivering its interim financial statements and MD&A for the three months ended March 31, 2020. Accordingly, the company will file the interim financials no later than the extended deadline of July 13, 2020. It confirmed that there have been no unannounced material business developments since the company filed its September 30, 2019, interim financial reports.
Pacific Empire Minerals Corp (CVE:PEMC) said the TSX Venture Exchange has accepted for filing documentation relating to an option agreement, dated May 25, 2020, between the company and several arm’s length parties, which will see Pacific Empire granted an option to acquire a 100% right, title and interest in certain mineral claims at the Jean Marie property, a copper-gold-silver-molybdenum porphyry project, located in central British Columbia. Under the terms of the agreement, the company will make aggregate cash payments of $675,000, issue an aggregate of 1.5 million common shares and incur a minimum of $2.7 million in exploration expenditures over a five-year period to earn the full interest in the property. Additionally, upon the exercise of the option, the optionors will retain a 2.5% net smelter return (NSR) royalty on the project, which is purchasable by the company at any time for $1.5 million. A further 0.25% of the NSR royalty can be purchased at any time for $1 million.
Loop Insights Inc (CVE:MTRX) said the TSX Venture Exchange has accepted for filing documentation with respect to its non-brokered private placement, announced on April 30, 2020, which will see the issue of 21,130,010 shares at a purchase price of 10 cents each, together with 21,130,010 share purchase warrants with an exercise price of 15 cents for a two-year period, with 46 placees.
Silver Range Resources Ltd (CVE:SNG) said the TSX Venture Exchange has accepted for filing documentation with respect to its non-brokered private placement, announced on February 11, 2020, which will see the issue of 5,225,000 shares at a purchase price of 8 cents each, together with 5,225,000 share purchase warrants at an exercise price of 16 cents for a two-year period, with seven placees.
Cardiol Therapeutics Inc. (TSX:CRDL) (OTCQX:CRTPF), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol products for heart diseases, has announced that it will webcast the company’s annual general meeting (AGM) of shareholders on June 1, 2020, at 4.30pm EDT. The virtual only meeting will be available via live audio webcast online at: https://web.lumiagm.com/112044985. Additional information on the AGM, including details on how to participate and vote, is available on the company’s website at: https://www.cardiolrx.com/investors/agm/
Milestone Scientific Inc. (NYSEAMERICAN:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, said in an interview with its interim-CEO, Leonard Osser will air on Bloomberg’s The RedChip Money Report television program on Sunday, May 31, at 3 pm local time. In the exclusive interview, it added, Osser discusses the company’s innovative technology, sales strategy, and product development efforts. To view the interview segment, investors can visit: https://youtu.be/PQEOQT27qFU. The interview will also air in the US on the Action Channel on Sunday, May 31 at 11am and on the Family Channel on June 3 at 6pm and is available via live stream on American Business TV.
Published at Fri, 29 May 2020 16:00:00 +0000-NA Proactive news snapshot: Biocept, EnWave, Lingo Media, Maverix Metals UPDATE …